RANOLAZINE IN ISCHEMIC HEART DISEASE

Abstract

Study results of a new anti-anginal drug (an inhibitor of sodium channels — ranolazine) are presented. Indications, contraindications, major clinical trials of the drug in patients with ischemic heart disease are considered.

Keywords

• ischemic heart disease
• angina
• acute coronary syndrome
• medication
• ranolazine